Peptide entry
Semaglutide
Also known as: Ozempic molecule, Wegovy molecule
Evidence / context
Evidence: Strong approved-drug evidence exists for the molecule; formulation and indication matter.
Available vial formats
- Conservative 0.25-0.5 mg once weekly (7.5-15 units per weekly injection)
- Standard 1.0-1.7 mg once weekly (30-51 units per weekly injection)
- Aggressive 2.4 mg once weekly (72 units per weekly injection) only if tolerated
- Cycle length 12-24+ weeks
- Best timing Same day each week; many prefer evening.
Titration schedule
- Weeks 1-4: 0.25 mg once weekly
- Weeks 5-8: 0.5 mg once weekly
- Weeks 9-12: 1.0 mg once weekly
- Weeks 13-16: 1.7 mg once weekly
- Week 17+: 2.4 mg once weekly maintenance
- Escalate every 4 weeks only if tolerated.
- If side effects are significant, hold the current dose for an extra 4 weeks before increasing.
- Smaller meals, hydration, electrolytes, protein, and fiber are key supports.
Reconstitution
- Swab vial tops with alcohol
- Draw 3.0 mL bacteriostatic water
- Inject slowly down vial wall (don't blast powder)
- Gently swirl - do not shake
- Rest 5-10 min to dissolve
- Refrigerate 2-8 C
Dosing, cycle & timing
- Conservative 0.25-0.5 mg once weekly (7.5-15 units per weekly injection)
- Standard 1.0-1.7 mg once weekly (30-51 units per weekly injection)
- Aggressive 2.4 mg once weekly (72 units per weekly injection) only if tolerated
- Cycle length 12-24+ weeks
- Best timing Same day each week; many prefer evening.
Support / expected effects
- Appetite suppression; reduced cravings.
- Improved glycemic control.
- Sustained fat loss with adherence.
Side effects / tolerability
- Nausea.
- Constipation/diarrhea.
- Reflux/heartburn.
Semaglutide Screening Notes
Screening should follow clinician guidance and the approved-drug context for GLP-1 medicines.
- Personal or family history of medullary thyroid carcinoma (MTC) or MEN2: clinician review before use.
- Prior pancreatitis: clinician review is needed.
- Significant gallbladder disease or severe gallbladder events: clinician review is needed.
- Severe GI disease, severe gastroparesis, or major motility issues: clinician review is needed.
- Pregnancy, trying to conceive, or breastfeeding: avoid unless directed by a qualified clinician.
- Diabetes medications, insulin, sulfonylureas, or hypoglycemia risk: clinician review because blood glucose can change.
- Vomiting, diarrhea, or poor intake can raise dehydration risk; pause escalation and address fluids/electrolytes if this occurs.
Practical tips
- Smaller meals; avoid high-fat early.
- Hydration + fiber.
- Hold dose longer if sides.
Storage
Refrigerated: ~45-60 days.
Related peptides
Related goal guides
Related categories
FAQ
What is Semaglutide explored for?
Appetite suppression; reduced cravings. Improved glycemic control. Sustained fat loss with adherence.
How is Semaglutide reconstituted?
1) Swab vial tops with alcohol 2) Draw 3.0 mL bacteriostatic water 3) Inject slowly down vial wall (don't blast powder) 4) Gently swirl - do not shake 5) Rest 5-10 min to dissolve 6) Refrigerate 2-8 C
What is a typical cycle length for Semaglutide?
12-24+ weeks
How are doses measured in syringe units here?
Units mean U-100 insulin-syringe gradations (1 mL = 100 units), not International Units. Use the calculator only when the vial concentration and injection volume are known.